Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 8/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 8/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10575617 | 0.87 | MAPT (0.48) | ADRB2ADRB1ADRB3PTPN1ALDH1A1 | |
| SCHEMBL1786925 | 0.85 | CHRM2 (0.51) | ADRB2ADRB1ADRB3PTPN1ALDH1A1 | |
| SCHEMBL31734114 | 0.84 | ATM (0.51) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL23484189 | 0.84 | ADRB2 (0.56) | ADRB2ADRB1ADRB3PTPN1ALDH1A1 | |
| SCHEMBL16759945 | 0.83 | MAPT (0.55) | ADRB2ADRB1ADRB3PTPN1ALDH1A1 | |
| SCHEMBL13789083 | 0.82 | ADRB2 (0.51) | ADRB2ADRB1ADRB3PTPN1ALDH1A1 | |
| SCHEMBL227395 | 0.81 | ALDH1A1 (0.62) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL16019900 | 0.81 | ALDH1A1 (0.62) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL109308 | 0.81 | ALDH1A1 (0.61) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL16217637 | 0.80 | ALDH1A1 (0.61) | ADRB2ADRB1ADRB3ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507612-B2 | Aziridine crosslinking agents for acrylic adhesives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2406338-B1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES CO (US) | 2012-11-28 | — | — | EP | disclosed |
| EP-2406338-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M Innovative Properties Company (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010104645-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | AAAS, ADGRF1, CDH1 | ADRB2 2417/4885ADRB1 2105/4885ADRB3 2946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.